Identification and optimisation of 3,3-dimethyl-azetidin-2-ones as potent and selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1)
3,3-Di-methyl-azetidin-2-ones were identified as potent and selective 11β-HSD1 inhibitors against the human and mouse forms of the enzyme. Structure guided optimisation of LLE was conducted, utilising a key polar interaction and identifying stereochemical preference for the 4S isomer. Metabolic stability was improved to afford oral exposure, providing tool compounds suitable for pre-clinical evaluation.
McCoull, William,Augustin, Martin,Blake, Caroline,Ertan, Anne,Kilgour, Elaine,Krapp, Stephan,Moore, Jane E.,Newcombe, Nicholas J.,Packer, Martin J.,Rees, Amanda,Revill, John,Scott, James S.,Selmi, Nidhal,Gerhardt, Stefan,Ogg, Derek J.,Steinbacher, Stefan,Whittamore, Paul R. O.
supporting information
p. 57 - 63
(2014/01/06)
More Articles about upstream products of 1587696-70-5